DCAT Elects New President

Sean Diver, director, commercial development, Small Molecule Drug Substance, Lonza AG has been elected as president of the Drug, Chemical & Associated Technologies Association (DCAT).

Also elected to serve as officers of DCAT are: Kerri McCullough Wood, senior vice president, head of commercial, Teva API and Medis, as first vice president; Sally Macaluso, vice president & chief procurement officer, Medical Devices and Business Services Procurement, Johnson & Johnson, as second vice president and finance officer; and Charles Davies, associate vice president, Global Sourcing & Procurement/Global Pharmaceutical Operations, Merck & Co. Inc. as third vice president.

All will serve one-year terms, ending October 31, 2021.

In addition, the following individuals have been newly elected or will continue to serve one-year terms as directors on the board.

• Elodie Cramer, associate director, Global Procurement, Biogen

• Lori Hoffman, head of alliance management, Slayback Pharma LLC

• Gavin Murdoch, senior director, Strategic Partnerships, Pharma Services Group, Thermo Fisher Scientific

• Steve Poland, director, 3rd Party FDF Sourcing, Mylan Inc.

• Scott Price, vice president, Sales, Ren-Pharm International